NCT04714398

Brief Summary

A 3-arm randomized pilot trial aimed at comparing the effectiveness of different approaches to recruiting patients to participate in a 6-month remote monitoring program for the management of hypertension (HTN).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
425

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 19, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

February 26, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 26, 2022

Completed
Last Updated

September 19, 2022

Status Verified

September 1, 2022

Enrollment Period

1.1 years

First QC Date

January 12, 2021

Last Update Submit

September 15, 2022

Conditions

Keywords

blood pressureremote monitoring

Outcome Measures

Primary Outcomes (1)

  • Proportion Participating by Recruitment Method

    The proportion of patients participating in each study arm out of the number randomized to that study arm.

    6 months, from date of consent to end of remote monitoring program

Secondary Outcomes (4)

  • Proportion Engaged by Recruitment Method

    6 months, from date of consent to end of remote monitoring period

  • Proportion with Controlled Blood Pressure by Monitoring vs. Usual Care

    6 months, from date of consent to end of remote monitoring program

  • Blood Pressure Trajectory by Recruitment Method

    6 months, from date of consent to end of remote monitoring program

  • Proportion of BP Measurements Submitted by Recruitment Method

    6 months, from date of consent to end of remote monitoring program

Study Arms (3)

Opt-In Recruitment

EXPERIMENTAL

All recruitment messaging will be framed for patients as they must opt-in to participate in the remote monitoring program.

Behavioral: Opt-In Recruitment

Opt-Out

EXPERIMENTAL

All recruitment messaging will be framed as though participation is the default, and patients must opt-out of participating in the remote monitoring program.

Behavioral: Opt-Out Recruitment

Usual Care

NO INTERVENTION

Patients in the usual care arm will not be contacted by study staff, they will not receive a blood pressure cuff, and they will not be asked to participate in any component of the blood pressure monitoring program.

Interventions

Patients in the opt-in recruitment arm will receive a letter describing the program and inviting them to participate in the remote monitoring program. Along with the letter they will receive an informational brochure and a copy of the informed consent form. Patients in this arm will then receive a recruitment phone call explaining the program and consenting the participant verbally. If the participant consents to participate in the remote monitoring program, to receive text messaging, and to connection to care, the research coordinator will mail a blood pressure cuff and begin the remote monitoring program for the patient 6 days later.

Opt-In Recruitment

Patients assigned to opt-out recruitment will receive a blood pressure cuff with instructions in the mail along with a letter describing the program and opt-out framing regarding their participation, as well as a brochure and a copy of the informed consent form. Patients in this arm will receive a recruitment phone call similar to recruitment arm A, explaining the program and consenting the participant verbally. If the participant consents to participate in the remote monitoring program, to receive text messaging, and to connection to care, the research coordinator will begin the remote monitoring program for the patient immediately.

Opt-Out

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between 18 and 75 years old with HTN (ICD-10 code I10)
  • Has had at least one office visit at Penn Family Care (PFC) within the past 12 months (at time of chart review), with the last visit having a BP reading exceeding HTN guidelines (150/90 if \>60 or, 140/90 if ages 21-59 yrs or has CKD or diabetes).
  • Must have a cellular phone with texting capabilities
  • Must be prescribed at least one medication for hypertension

You may not qualify if:

  • Has metastatic (Stage IV) cancer
  • Has end stage renal disease
  • Has congestive heart failure
  • Has dementia
  • BMI \>= 50
  • Is Non-English speaking requiring a translator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (1)

  • Mehta SJ, Teel J, Okorie E, Reitz C, Purcell A, Snider CK, Clark K, Kersting RC, Glanz K, Putt M, Rareshide C, Volpp KG. Behavioral Economic Framing for Enrollment and Retention of Patients in Remote Blood Pressure Monitoring: A Randomized Clinical Trial. JAMA Netw Open. 2025 Sep 2;8(9):e2529825. doi: 10.1001/jamanetworkopen.2025.29825.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Shivan Mehta, MD, MBA

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 12, 2021

First Posted

January 19, 2021

Study Start

February 26, 2021

Primary Completion

March 21, 2022

Study Completion

August 26, 2022

Last Updated

September 19, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations